In vitro and in vivo Pharmacological Activities of 14-O-Phenylpropyloxymorphone, a Potent Mixed Mu/Delta/Kappa-Opioid Receptor Agonist With Reduced Constipation in Mice-Reference-Cited by-同舟云学术

In vitro and in vivo Pharmacological Activities of 14-O-Phenylpropyloxymorphone, a Potent Mixed Mu/Delta/Kappa-Opioid Receptor Agonist With Reduced Constipation in Mice

Published:2018-08-31 Issue: Volume:9 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Lattanzi Roberta,Rief Silvia,Schmidhammer Helmut,Negri Lucia,Spetea Mariana

Funder

Austrian Science Fund

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference61 articles.

1. Will peripherally restricted kappa-opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential?;Albert-Vartanian;J. Clin. Pharm. Ther.,2016

2. Opioid peptides: potential for drug development.;Aldrich;Drug Discov. Today Technol.,2012

3. Opioid ligands with mixed mu/delta opioid receptor interactions: an emerging approach to novel analgesics.;Ananthan;AAPS J.,2006

4. Hopes for the future of pain control.;Bannister;Pain Ther.,2017

5. Pharmacological investigations of N-substituent variation in morphine and oxymorphone: opioid receptor binding, signaling and antinociceptive activity.;Ben Haddou;PLoS One,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peripheralization Strategies Applied to Morphinans and Implications for Improved Treatment of Pain;Molecules;2023-06-14

2. CYX-5, a G-protein biassed MOP receptor agonist, DOP receptor antagonist and KOP receptor agonist, evokes constipation but not respiratory depression relative to morphine in rats;Pharmacological Reports;2023-01-13

3. A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse;European Journal of Medicinal Chemistry;2022-12

4. Investigation of the μ‐ and κ‐opioid receptor activation by eight new synthetic opioids using the [ ³⁵ S]‐GTPγS assay: U‐47700, isopropyl U‐47700, U‐49900, U‐47931E, N ‐methyl U‐47931E, U‐51754, U‐48520, and U‐48800;Drug Testing and Analysis;2022-03-03

5. Pharmacological and metabolic characterization of the novel synthetic opioid brorphine and its detection in routine casework;Forensic Science International;2021-10